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1. Supplementary Results: 
 
a) Flux control coefficient calculation from transient data 
Supplementary Table 1: Coefficients ‘α’ from transient metabolite data using 
multiple linear regression according to equation  (3) and calculation of flux control 
coefficients ‘C’ according to equation (2) (Supplementary Methods), More detailed 
information can be found in Supplementary Methods. The signal to noise ratio (S/N) 
of the FCCs was calculated to obtain an indication for the reliability. Except for HK 
and FBA, noise was higher than the actual signal.  
No  R2  Regression Coefficients  Flux Control Coefficients 
  const.  αGLUC  αG6P/F6P  αFBP  αDHAP  α2/3PG/PEP  αPYR αATP CHK  CPFK  CFBA  CGAPDH  CPK  CLDH 
1  0.9993  4.5  ‐0.6  16.5  ‐5.8  95.7  0.5  17.0  ‐9.6  0.20  ‐0.09  0.75  ‐0.07  0.05  ‐0.13 
2  0.9981  8.3  ‐0.4  8.8  ‐54.9  78.5  27.6  9.8  ‐16.4  0.17  ‐0.31  0.87  0.07  ‐0.22  ‐0.06 
3  0.9985  5.3  ‐0.1  0.5  ‐35.9  65.2  36.2  33.5  ‐19.6  0.16  ‐0.13  0.79  0.13  ‐0.17  ‐0.26 
4  0.9997  5.1  ‐0.4  16.1  4.7  121.0  ‐34.8  3.7  ‐11.0  0.18  0.00  0.78  ‐0.31  0.18  ‐0.02 
5  0.9994  6.5  ‐0.5  11.6  ‐48.3  60.1  37.6  5.1  ‐18.7  0.20  ‐0.27  0.71  0.12  ‐0.34  ‐0.03 
6  0.9981  ‐3.2  ‐0.6  59.0  19.5  83.8  14.7  14.4  13.4  0.33  ‐0.38  0.46  0.20  0.10  ‐0.10 
7  0.9994  4.7  ‐0.4  17.8  2.4  112.9  ‐11.5  ‐2.2  ‐9.2  0.20  ‐0.05  0.81  ‐0.15  0.00  0.02 
8  0.9997  4.6  ‐0.3  15.3  ‐1.3  109.1  ‐26.2  9.0  ‐11.1  0.18  ‐0.04  0.75  ‐0.25  0.16  ‐0.06 
9  0.9993  5.4  ‐0.4  9.3  ‐6.0  98.4  ‐26.6  16.5  ‐13.5  0.17  ‐0.01  0.77  ‐0.30  0.22  ‐0.12 
10  0.9997  4.3  ‐0.4  17.4  ‐6.7  93.9  ‐6.0  3.5  ‐8.7  0.18  ‐0.11  0.69  ‐0.10  0.01  ‐0.02 
11  0.9994  6.7  ‐0.2  5.5  ‐11.3  106.8  ‐24.2  1.7  ‐15.1  0.16  ‐0.01  0.91  ‐0.30  0.08  ‐0.01 
12  0.9977  5.4  ‐0.9  29.9  ‐52.4  52.4  63.2  16.4  ‐5.9  0.30  ‐0.62  0.85  0.46  ‐0.43  ‐0.13 
  Mean (S) 0.18  ‐0.10  0.78  ‐0.08  0.03  ‐0.06 
  Standard deviation (N) 0.05  0.19  0.11  0.24  0.21  0.08 
  S/N 3.6  0.5  7.1  0.3  0.1  0.75 
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b) Enzyme sources and activities 
Supplementary Table 2: Kinetic parameters of E. coli’s glycolytic enzymes and the 
commercially available glycolytic enzymes used for screening. The unit equivalent 
(Ueq) was calculated by determining the enzyme activity of commercially available 
enzymes under the reaction conditions used in this study. All units mentioned in this 
study refer to the activities reported here, not to the units given by the manufacturer. 
As glucokinase and hexokinase catalyze the same reaction, hexokinase (HK) was 
used as a synonym for glucokinase (Glk) to prevent confusion. 
Enzyme EC. No Substrates E. coli enzymes  Commercially available enzymes  





GLUC 0.51 – 3.762  0.043 – 0.474 S. cerevisiae 0.9 
ATP 0.151 – 0.782  0.15  
Glucosephosphate 
isomerase 
5.3.1.9 G6P 0.286  0.3 – 1.57 S. cerevisiae n.d. 
6-phosphofructo-
kinase 
2.7.1.11 F6P 0.124 8, a  0.0239 – 0.0310 B. stearothermophilus 2.2 
ATP 0.1188,  a  0.0710 – 0.129   
Fructose-
bisphosphate aldolase 




1.2.1.12 GAP 0.8913  0.0914 Rabbit muscle n.d. 
NAD 0.45 13  0.0614   
Pi 0.5313  n.a.   
Phosphoglycerate 
kinase 
2.7.2.3 1,3PG n.a.  n.a. S. cerevisiae n.d. 
ADP n.a.  0.1815   
Pyruvate kinase 2.7.1.40 PEP 0.08 – 3.6316, b  n.a. Rabbit muscle n.d. 





PYR 7.217  0.7618 Rabbit muscle 0.9 
NADH 7.017  n.a.   
a geometric mean of available data as reported8 
b depending on the concentration of the allosteric regulator FBP 
c Unit equivalent: one manufacturer’s unit corresponds to the indicated unit as measured under the conditions applied in this 
study 
n.d. not determined, because the enzyme did not show any effect when added in excess 
n.a. not available 
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c) Improved reproducibility after addition of HK and FBA 
 
 
Supplementary Figure 1: Examples of DHAP and PEP time courses using aliquots 
of the same cell free extract without (a-b) and with addition of HK and FBA (c-d). 
Clearly, the system behavior becomes more reproducible after the addition of HK and 
FBA. DHAP and PEP curves were chosen as they represent extreme cases of good 
and bad reproducibility. 
 
d) Coupling of the concentration time courses of 2PG/3PG and PEP 
 
Supplementary Figure 2: The concentrations of metabolites 2PG/3PG and PEP are 
closely coupled. (a-d) Representative curves of 2PG/3PG and PEP time courses 
from experiments in which the supplementation of different combinations of purified 
HK, FBA and PFK showed that the 2PG/3PG and PEP concentrations are closely 
coupled.  
Nature Chemical Biology: doi:10.1038/nchembio.541
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e) Single enzyme perturbations in the lower part of glycolysis 
 
 
Supplementary Figure 3: Single enzyme perturbations in the lower part of glycolysis 
using E. coli’s in vitro optimized upper part of glycolysis (W3110 ∆amn 
tpiA::kn+LDH+HK+FBA) realizing all 8 possible combinations of additions of the 
enzymes GAPDH, PGK and PK suggested no rate limiting step in the lower part of 
glycolysis. Reactions were started by injection of CFX in vitro supplemented with 
enzymes from the upper part of glycolysis (5 U HK and 5 U FBA) followed by 
stepwise addition of enzymes of the lower part of glycolysis as indicated. 
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f) Modulation of FBA activity 
 
Supplementary Figure 4: Optimization of HK and FBA activities using commercially 
available enzymes and CFX from W3110 ∆amn tpiA::Kn by investigating the effect of 
enzyme additions on DHAP production. (a) An increase in HK activity leads to higher 
levels of G6P/F6P. (b) Simultaneous reduction of HK and FBA shows that a 
reduction by a factor of two is still sufficient for a 2.5-fold higher DHAP production 
compared to the non-optimized system. (c) Reduction of FBA activity while 
maintaining HK activity constant shows that further reduction to 0.1 U mL-1 is 
sufficient for DHAP production. 
  
Nature Chemical Biology: doi:10.1038/nchembio.541
8 
 
g) Analysis of the performance of operon glk-fba-ldh with pUC ori 
  
Supplementary Figure 5: Analysis for rate limiting steps using CFX from the operon-
carrying E. coli W3110 ∆amn tpiA::kn. (a) Supplementation of CFX with commercially 
available PFK could elevate the production of DHAP. Enzyme activities refer to units 
(U) per mL reactor volume and were determined by an in vitro assay 
(Supplementary Methods). 
 
h) Analysis of the performances of operon glk-fba-ldh with pBR322 ori and the 
operon fba-ldh-glk with pUC ori 
 
Supplementary Figure 6: Operon tuning for reducing HK activity. (a) Reduction of 
the copy number of the plasmid carrying the operon without induction shows similar 
DHAP production to CFX without operon expression. (b) Changing the order of 
genes in the operon did not lead to high DHAP production. In all cases CFX from E. 
coli W3110 ∆amn tpiA::kn was used. Enzyme activities refer to units (U) per mL 
reactor volume as determined by an in vitro assay (Supplementary Methods). 
Nature Chemical Biology: doi:10.1038/nchembio.541
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2. Supplementary methods: 
a) Normalization by an internal standard: The absolute ion counts of the 
metabolites obtained from the enzyme-membrane reactor and measured in the MS 
are prone to fluctuations because of flow rate variations or day to day variations of 
the electrospray-ionization and therefore require normalization against an internal 
standard. We supplied 3-N-morpholino-propanesulfonic acid (MOPS) to the reactor 
feed medium, which is a biologically inert buffer and shows good signal intensity. 
Flow rate fluctuations can lead to a different dilution of the reactor outlet (fluctuations 
at S1) or to a different flow rate in the ESI ion source (fluctuations at S2). We have 
measured the flow rate of the waste streams of our reactor setup which allowed an 
estimated on the flow splitting at S1 and S2 (Fig. 1). We could not detect any major 
fluctuations at these mixing tees. However, the splitting ratio was not recorded online 
in the final measurement setup and could theoretically change over the course of an 
experiment. We therefore analyzed whether an internal standard can compensate for 
flow-rate fluctuations within in the setup. We doubled or halved the standard flow 
rates and recorded the influence on MOPS-normalized signals. As shown in 
Supplementary Fig. 7, the influence of the flow rate fluctuations in this setup was 
minor for fluctuations at S1 (Supplementary Fig. 7a). It should be emphasized that a 
different flow rate (by a factor of 2) at S1 doubles or halves the total concentration of 
e.g. G3P that is measured in the MS after dilution. Normalization against MOPS after 
a doubled or halved flow rate at S1 only shows a difference in normalized signal 
intensity of roughly 10% which is rather low compared to twice or half of the G3P 
signal without normalization. Given the large fluctuations imposed in this control 
experiment, we felt that these influences were acceptable. The influence of 
fluctuations at S2 was negligible (Supplementary Fig. 7b). In summary, 
normalization against an internal standard compensates for flow-rate fluctuations 
Nature Chemical Biology: doi:10.1038/nchembio.541
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Supplementary Figure 7: Compensation of flow rate fluctuations within the setup by 
normalization against MOPS. (a) Flow rate fluctuations by a factor of two at S1 lead 
to a different dilution ratio of the reactor outlet, which can be compensated for by 
normalization against an internal standard. Note that the applied flow rate fluctuations 
are rather drastic. (b) Flow rate fluctuations by a factor of two at S2 leading to lower 
or higher flow rates into the ESI ion-source do not influence the normalized signal. 
 
b) Calibration and quantification. Multi-enzyme network dynamics show changes 
in metabolite concentrations over several orders of magnitude. As the setup 
developed in this study operates at a fixed dilution rate, calibration curves over a 
broad concentration range were essential. Calibration for online quantification was 
performed using a syringe pump operated at 30 μL min-1 using three standard mixes 
containing five compounds at 1 mM. By splitting the calibration mix in three, we could 
prevent experimentally unrealistically high total ion concentrations. Standard mixes 
were prepared from pure compound stock solutions (50 mM stock solutions in water) 
Nature Chemical Biology: doi:10.1038/nchembio.541
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and frozen in aliquots at -80 °C. The standard mixes were diluted in calibration buffer 
which had a similar salt concentration as for online analysis (75% MeOH; 5 mM 
NH4COOH; pH 4.8; 0.025 mM MgCl2; 0.02 mM Na2HPO4; 0.5 mM NH4HCO3; 4 μM 
MOPS). Signal intensities of the different compounds were normalized against the 
MOPS signal and then used for quadratic regression. The limit of detection (LOD) 
and limit of quantification (LOQ) were calculated using a signal to noise ratio of 3 and 
10, respectively. 
To obtain concentration values from raw data the ion current from each compound is 
normalized against the ion current of MOPS. The normalized value is then converted 
to concentrations using a corresponding normalized calibration curve and the dilution 
factor is included to obtain real reactor concentrations.  
To meet the demand for a broad quantification range, quadratic calibration curves 
were established (Supplementary Table 3) since the calibration curves for most 
compounds only showed a linear behavior up to a concentration of approximately 10 
µM at the ion source (data not shown). As the coefficients of the quadratic terms 
were generally two orders of magnitude smaller than those of the linear terms, they 
only became relevant for high compound concentrations, meaning that they were 
essentially zero for very low concentrations. Using quadratic calibration curves 
allowed us to cover a concentration range of at least three orders of magnitude for all 
compounds with a maximum reactor concentration of 2.5 mM. An exception was 
glucose which covered a range up to 5 mM and NADH which covered a range up to 
1.25 mM. Within these ranges quantification errors were generally smaller than 10% 
regardless whether high or low concentrations were considered.  
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Supplementary Table 3: Calibration data for glycolytic intermediate quantification. 
Limit of detection (LOD, at a signal to noise ration of S/N=3) and limit of quantification 
(LOQ, S/N=10) refer to concentrations in the reactor; hence, the concentrations 
measured at the ion-source are 100 times lower. Regression data were obtained by 
fitting to a quadratic calibration curve y=ax2+bx. Note that the coefficient in the 
quadratic term is always two to three orders of magnitude smaller than the coefficient 
in the linear term, indicating that the quadratic term is only a small correction for high 
metabolite concentrations. A 3PG calibration curve was used to quantify the 
overlapping 2PG/3PG pool and G6P to quantify the overlapping G6P/F6P pool (see 
also 1d).  
LOD [mM] LOQ [mM] R2 a [mM-2] b [mM-1] 
PYR 3.65E-02 6.05E-02 0.9998 2.61E-05 3.92E-03 
LAC 6.89E-01 1.69E+00 0.9997 2.86E-05 4.31E-03 
PEP 4.84E-04 9.44E-04 >0.9999 -3.50E-04 1.63E-01 
DHAP 2.34E-03 7.33E-03 0.9999 -8.43E-04 1.69E-01 
GAP 1.44E-03 3.19E-03 >0.9999 -4.09E-05 6.94E-03 
G3P 2.08E-03 4.03E-03 0.9999 -7.50E-04 1.65E-01 
GLUC 3.20E-02 1.02E-01 >0.9999 -1.16E-04 1.60E-02 
2PG 4.29E-03 1.31E-02 0.9999 -5.52E-04 1.33E-01 
G6P 1.39E-03 3.30E-03 0.9998 -1.59E-03 1.80E-01 
FBP 8.21E-04 1.67E-03 0.9998 -1.05E-03 1.65E-01 
AMP 1.40E-03 3.23E-03 >0.9999 -7.86E-05 3.44E-02 
ADP 1.02E-02 2.37E-02 >0.9999 -3.95E-04 8.06E-02 
ATP 2.79E-03 6.41E-03 0.9998 2.75E-04 2.27E-02 
NAD 2.47E-03 6.30E-03 >0.9999 -1.78E-03 1.28E-01 
NADH 2.98E-03 9.86E-03 0.9998 -2.90E-04 2.93E-02 
 
 
c) Compensation of MS-signal overlaps. Since direct injection ESI-MS analysis 
without chromatographic separation was performed, overlapping MS-signals needed 
to be resolved. Overlapping signals have been reported previously19,20 and can occur 
if MRM transitions are not specific for a certain compound. For the set of metabolites 
analyzed here, the two compound sets G6P/F6P as well as 2PG/3PG could not be 
Nature Chemical Biology: doi:10.1038/nchembio.541
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distinguished from each other since they showed exactly the same fragmentation 
patterns and intensities. Subsequently, only the G6P/F6P and 2PG/3PG pools rather 
than individual concentrations were determined in the following analyses. 
The two compounds FBP and GAP showed overlapping signals at the MRM 
transition of DHAP (Supplementary Fig. 8a) but could be distinguished from DHAP 
using unique fragment ions. The “false positive” signal of FBP at the DHAP transition 
was very low and could be neglected. The “false positive” signal of the phosphate ion 
of GAP at the DHAP transition was only 30% lower than the DHAP signal itself 
(Supplementary Fig. 8a). Here, a unique fragmentation pattern of GAP could be 
used for its exact quantification and allowed for calculating the contribution of the 
overlapping GAP signal. To confirm this, we measured first samples containing 
equimolar amounts of GAP and DHAP, which showed, as expected, higher signals at 
the DHAP-transition compared to samples containing the same amount of DHAP 
only. When the overlapping GAP signal was subtracted from the signal of the 
equimolar mixture, the corrected values were identical to those measured for DHAP 
alone, indicating that the correction method was accurate (Supplementary Fig. 8b). 
In this study, the DHAP signal was corrected for the overlapping GAP signal as soon 
as GAP could be quantified in the sample. However, please note that in the vast 
majority of scenarios described here, the GAP concentration remained below the 
LOQ and correction was therefore not necessary. However, we can correct the signal 
for false positive fractions in case reliable GAP concentrations are measured in future 
experiments. 
A similar observation was made for the NAD+ and NADH signals. NADH showed an 
overlapping signal with the MRM-transition of NAD+, which could be corrected by 
subtracting the false positive signal of NADH, as shown by the identity of a curve 
obtained from NAD+ alone and one obtained from measuring the NAD+ signal from 
Nature Chemical Biology: doi:10.1038/nchembio.541
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an equimolar mix of NAD+ and NADH and then subtracting the NADH-specific 
contribution (Supplementary Fig. 8c-d). In this study, the NAD+ signal was corrected 
for the overlapping NADH signal when NADH was present above the LOQ. 
 
  
Supplementary Figure 8: Correction of overlapping signals of the compound sets 
DHAP-GAP and NAD+-NADH. (a) Normalized DHAP signal at the MRM-transition of 
DHAP and the “false positive signal” ratios of FBP and GAP at the same transition. 
(b) The “false positive” contribution of the GAP signal at the DHAP transition can be 
accurately corrected by subtraction, as shown by subtracting the GAP signal 
(evaluated at a different and unique MRM transition) from the joint DHAP/GAP signal 
at the DHAP transition. (c) “False positive” signal of NADH at the MRM-transition of 
NAD+. (d) Correction of the “false positive” NADH signal at the NAD+-transition: 
Nature Chemical Biology: doi:10.1038/nchembio.541
15 
 
Subtraction of the false positive NADH signal (evaluated  at a different and unique 
MRM transition) from the signal obtained for equimolar amounts of NAD+ and NADH 
coincides with the curve obtained for NAD+ only.  
 
d) Analysis of ion-specific matrix effects. The effect of ion suppression is a well 
known phenomenon in ESI-MS analysis and can be regarded as the major limitation 
for the method21. An understanding of the impact of ion suppression is essential for 
the validation of the presented method21 and particularly for online measurement of 
glycolytic intermediates since the quantitative measurements will be performed in a 
dynamically changing matrix without prior chromatographic separation. In order to 
analyze potential matrix effects, standard addition of pure compounds to two 
physiological samples from in vitro batch conversion of glucose and ATP was 
performed as reported previously22. Briefly, two samples were taken (after 30 min 
and 120 min) from a 10 mL batch reaction at 37°C (100 mM NaHCO3 pH 7.7; 5 mM 
MgCl2; 0.8 mM KCl; 11.1 mM GLUC; 11.1 mM sodium phosphate pH 7.7; 5.75 mM 
NAD+; 1 mg mL-1 CFX (W3110 ∆amn tpiA::kn); 11.1 mM ATP). The reaction was 
inactivated by adding one volume of isopropanol and chilling on ice, precipitated 
proteins were removed by centrifugation. The supernatant was diluted 1:500 in 
calibration buffer (75% MeOH; 5 mM NH4COOH; pH 4.8; 0.025 mM MgCl2; 0.02 mM 
Na2HPO4; 0.5 mM NH4HCO3; 4 μM MOPS) which contained various compounds at 
different concentrations that were typical for our experiments. To these samples the 
specific compound was added from a 100-fold stock solution in different 
concentrations yielding final added concentrations of 0.625; 1.25; 2.5 and 5 μM. 
Samples were analyzed using a syringe pump at 30 μL min-1. The increase in signal 
for the specific compound was determined, leading to two calibration curves (one for 
each original sample) with different intercepts on the ordinate depending on how 
Nature Chemical Biology: doi:10.1038/nchembio.541
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much of the specific compound was in the original sample to start with. Such 
standard addition curves were recorded for all compounds in both samples 
(Supplementary Fig. 9). As normalized signal intensities were still in the linear 
range, experiments were evaluated by calculating the relative deviation of the slope 
(in percent) of standard addition experiments in the two matrices. 
The effect of ion suppression for the specific compound was then estimated from the 
ratio of the two calibration curves, each recorded in a different but still typical 
concentration matrix (Supplementary Table 4). In the absence of any ion 
suppression effect, the two slopes should be identical irrespective of the background; 
the ratio of the two slopes should be 1 (100%). The obtained slope ratios varied 
between 94.7% for pyruvate and 106.5% for ADP. In summary, these results 
indicated that in the system under study ion suppression effects were only a minor 
issue, as slopes were nearly identical and the added compounds only showed a 
minor impact onto the signals of the non-added compounds (Supplementary Fig. 9).  
  




Supplementary Figure 9: Analysis of ion-suppression by standard addition 
experiments for 16 different compounds. The respective compound was added to 
0.625, 1.25, 2.5 and 5 μM to two different samples (black and grey) obtained at two 
different time points from DHAP production experiments with an E. coli in vitro 
glycolysis. Note that these added concentrations reflect the situations in the 
ionization chambers, concentrations in the reactor are consequently 100 times 
higher. Normalized signal intensities of the respective compound and the recorded 
Nature Chemical Biology: doi:10.1038/nchembio.541
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signal intensities of the non-added compounds are shown (in total 10 signal 
intensities per compound: two experiments, five measurements each (first, no 
addition, and then 4 additions of the specific compound). Note that the two sets of 
concentration for the added compound have to differ, as the two samples used for 
standard addition contained different concentrations of the corresponding compound. 
The two slopes for the added compound were calculated and the slope ratio is shown 
in Supplementary Table 4.  
 
Supplementary Table 4: Analysis of ion suppression for the glycolytic intermediates 
studied. Standard additions (0.625; 1.25; 2.5; 5 μM, concentrations as injected in the 
ESI-chamber) of each compound were performed to two different samples and the 
ratio of the two slopes of signal over concentration is shown.  
compound PYR LAC PEP DHAP GAP G3P GLUC 2PG 
slope ratio [%] 94.7 95.7 101.9 97.8 103.5 97.5 101.2 99.4 
         
compound G6P F6P FBP AMP ADP ATP NAD+ NADH 
slope ratio [%] 97.7 97.7 97.6 99.4 106.5 98.9 103.8 102.0 
  
 
e) Characterization of the metabolic real-time analysis setup. For an accurate 
quantification during rapid concentration changes, it is important to know whether the 
concentrations measured in the MS truly reflect the concentrations in the reactor or 
whether the passage of the fluid through splitting and mixing tees has significantly 
influenced the shape of the curves of concentration over time. The impact of the 
different parts of the setup (reactor, dilution device and membrane) was 
characterized by analyzing the concentration over time of a tracer pulse at the MS. 
For all experiments G3P was used as a tracer and MOPS was used as the internal 
standard. The signal was quantified after normalization using a standard curve for 
Nature Chemical Biology: doi:10.1038/nchembio.541
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G3P recorded at the corresponding flow rate at the ESI ion source (30 μL min-1 for 
experiments with the dilution device and 250 μL min-1 for experiments without the 
dilution device). The feed solution was 400 μM MOPS in pure water for experiments 
with the dilution device which was then diluted with matrix buffer (75% MeOH, 5 mM 
NH4COOH, pH 4.8). Without the dilution device matrix buffer with 4 μM MOPS was 
used.  
The reactor itself showed a dead time of 0.5 min when operated without the dilution 
device (S1, T, and S2, see Fig. 1). The dilution device prolonged the dead time by 1 
min because of the tubing. The concentration time course obtained due to the 
residence time distribution in the reactor was hardly changed by the dilution device, 
indicating that the dilution did not cause significant disturbances of the signal. When 
the reactor was fitted with a membrane to retain the enzymes of the CFX, the curve 
flattened slightly and showed a retarded peak, but residence time profiles were 
reproducible for the 10 glycolytic metabolites and 5 cofactors studied here 
(Supplementary Fig. 10). We are currently working on protocols for the 
mathematical correction of this slight change in signal from reactor interior to ESI-
chamber, but argue that this minor effect is of no relevance for the results presented 
in this work. 
Once the separate items of the setup had been characterized with G3P only, the 
results were confirmed for all compounds with the final setup. Here, the dynamics of 
200 μL pulses of 4 compounds (12.5 μM each) was recorded for 1 h. Primary data 
were first normalized against MOPS and are shown as signal intensities relative to 
the maximum signal intensity of each compound (Supplementary Fig. 10b).  
 




Supplementary Figure 10: Dynamic behavior of the reactor setup. (a) Residence 
time profile of a G3P pulse of the setup operated with and without the dilution device 
and with a membrane. (b) Relative residence time profiles of investigated 
metabolites, normalized to their maximum intensity. 
 
f) Measuring frequency. In this study 15 compounds plus MOPS as an internal 
standard were analyzed in parallel, which means that the measurement time (dwell 
time) for each compound has an impact on time-resolution. Therefore, the impact of 
measuring frequency on data quality after normalization against the internal standard 
was analyzed. The signal to noise ratio at dwell times per compound of 5 to 2500 ms, 
which corresponds to time-resolutions between 6.3 Hz and 0.02 Hz (based on the 
analysis of 16 compounds), was analyzed and revealed better data quality for lower 
time-resolutions (Supplementary Fig. 11). The beneficial effect of longer dwell times 
becomes obvious at a dwell time of 1000 ms and 2500 ms, where the noise is about 
60 to 100 times lower than the signal. The analysis in this study was performed at 
0.125 Hz (7.5 measurements per minute) which in our view was a good tradeoff 
between data density and signal quality, but an increase in time-resolution by a factor 
of five would be easily possible if required, with only minor consequences for data 
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Supplementary Figure 11: The impact of measurement frequency on data quality. 
(a) Signal stability of the normalized G3P/MOPS signal at different dwell times or 
time-resolutions (in Hz, based on 16 MRM transitions). (b) Signal to noise ratio at 
different dwell times. The standard deviation of the normalized ion count was used as 
a measure for the noise and the mean as signal.  
 
g) Calculation of flux control coefficients. Flux control coefficients (FCCs) from 
dynamic metabolite time courses were calculated as described previously23,24. The 
method has two limitations: First, it assumes linear rate equations in the relevant 
substrate concentration ranges, which is not necessarily the case. However, the 
influence of non-linearity is usually limited24.  Second, the method is sensitive to 
measurement inaccuracies25. However, we argue that this problem is eliminated to a 
large extent by metabolic real-time analysis, which gives continuous, high frequency 
data with high consistency when compared to traditional enzyme-based assays or 
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discretely withdrawn samples for HPLC-MS analysis. Briefly, the method is applied 
as follows: a set of coefficients αj can be calculated for a K-enzyme pathway from 
transient metabolite time courses by multiple linear regression of time  
(t) on the dynamic time course cj(t) according to Eq. (1). 




The FCCs of the pathway are related to αj via the steady state flux J and 
stoichiometric matrix S. 
൫ܥଵ௃ ܥଶ௃ … ܥ௅௃൯ ൌ ሺߙଵ ߙଶ … ߙ௄ሻ ∗ ܵ ∗ ܬ                ሺ2ሻ 
For FCC calculation the time period from 5.5 – 19 min from Fig. 3 comprising 100 
data points was used which showed the largest dynamic changes, thereby 
minimizing the collinearity of regression coefficients.  
For the pathway studied here, the following assumptions were made: G6P and F6P 
are in equilibrium and were lumped into one reaction; 2PG/3PG and PEP were in 
equilibrium (Supplementary Fig. 2) and are also lumped into one reaction; as GAP 
was always below the LOQ it was assumed to react rapidly to 1,3-PG and therefore 
GAP-DH and PGK were also lumped into one reaction. The reactions from ADP to 
AMP as well as from DHAP to G3P were neglected and consequently the pathway 
was treated as linear. As the NAD+ time course was constant it could be considered 
as a constant external metabolite and was therefore omitted from FCC calculation. 
Based on these assumptions the pathway can be described by the following 
stoichiometric matrix:  
 
 
















GLUC  ‐1  0  0  0  0  0 
G6P  1  ‐1  0  0  0  0 
FBP  0  1  ‐1  0  0  0 
DHAP  0  0  1  0  0  0 
GAP/1,3PG  0  0  1  ‐1  0  0 
2/3PG/PEP  0  0  0  1  ‐1  0 
PYR  0  0  0  0  1  ‐1 
LAC  0  0  0  0  0  1 
ATP  ‐1  ‐1  0  1  1  0 
ADP  1  1  0  ‐1  ‐1  0 
  
For the calculation of the regression coefficients αj, the regression coefficient 
αGAP/1,3PG was set to zero as it could not be measured, αLAC was set to zero as LAC 
was below the LOQ and αADP was set to zero to avoid collinearity of ATP and ADP 
because of the mass balance equation. Considering starting concentrations of ATP 
and GLUC by a constant term, Eq. (1) can be written as: 
 
ߙீ௅௎஼ܿீ௅௎஼ሺݐሻ ൅ ߙீ଺௉ ி଺௉⁄ ܿீ଺௉ ி଺௉⁄ ሺݐሻ ൅ ߙி஻௉ܿி஻௉ሺݐሻ ൅ ߙ஽ு஺௉ܿ஽ு஺௉ሺݐሻ ൅
ߙଶ ଷ௉ீ⁄ /௉ா௉ܿଶ ଷ௉ீ⁄ ௉ா௉⁄ ሺݐሻ ൅ ߙ௉௒ோܿ௉௒ோሺݐሻ ൅ ߙ஺்௉ ஺்ܿ௉ሺݐሻ ൅ ܿ݋݊ݏݐ ൌ ݐ                              ሺ3ሻ  
The steady state DHAP flux was calculated by dividing steady state DHAP 
concentrations through the residence time τ=40 min. FCCs could then be calculated 
by applying Eq. (1). 
 
h) Full factorial set of perturbations. All possible combinations of enzyme additions 
were realized in order to analyze the influence of each combination on DHAP 
production. This could be performed in six metabolic real-time analysis runs 
(Supplementary Table 5) by adding the next enzyme when steady concentrations of 
DHAP were reached. 
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Supplementary Table 5: Full factorial experimental design for all 16 possible 
combinations of single enzyme additions. The 16 combinations can be realized in 6 
experiments (a-f) by stepwise addition of enzymes in each experiment (in the order 
according to subscripts). 
 No.  HK  PGI  PFK FBA
 1  - -  - -
a  
2  + 1  -  - -
3  +  +2  - -
4  +  +  +3  -
b  
5  - -  +1  -
6  - -  + +2 
7  +3  -  + +
c  
8  - +1  - -
9  - +  +2  -
10  - +  + +3 
d  
11  - -  - +1 
12  - +2  - +
13  +3  +  - +
14  +  +  +4  +
e  15  +1  -  +2  -
f  16  +1  -  - +2 
 
i) Activity measurements. Enzyme activities were determined 
spectrophotometrically in a temperature controlled (30°C) 96-well plate reader 
(Perkin Elmer, Waltham, Massachusetts, USA) by measuring the 
production/consumption of NAD+/NADH or NADP+/NADPH via a change in the 
absorbance at 340 nm. All assays were performed in 50 mM NH4HCO3; 2.5 mM 
MgCl2. Enzyme-specific conditions were as follows: HK: 5 mM glucose, 2.5 mM ATP, 
0.5 mM NADP+, 1.75 U mL-1 glucose-6-phosphate dehydrogenase; PFK: 5 mM 
fructose-6-phosphate, 2.5 mM ATP, 0.5 mM NADH 1.7 U mL-1 glycerol-3-phosphate 
dehydrogenase, 0.4 U mL-1 fructosebisphosphate aldolase; FBA: 5 mM 
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fructosebisphosphate, 0.5 mM NADH, 1.7 U mL-1; LDH:  5 mM pyruvate, 0.5 mM 
NADH. The slope of the linear part of the curve recorded at 340 nm and the protein 
concentration was used to calculate the specific enzyme activity in the CFX. The 
activities of commercially available enzymes were different from those given by the 
supplier and the conversion factors can be found in Supplementary Table 2. 
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